Basel Medical Group Ltd Ordinary Shares (BMGL) Stock Analysis & Winston Score
Basel Medical Group is a healthcare company based in Singapore that provides medical services to patients across Southeast Asia. It operates outpatient clinics and specialist centers, offering services like general medicine, aesthetics, and other healthcare treatments. The company serves everyday patients looking for affordable, accessible medical care in the region. Basel Medical Group makes money by charging patients directly for clinic visits and medical procedures, rather than through insurance subscriptions or software licenses. The company is small, with a market capitalization near zero, and it operates primarily in Singapore with some regional presence. Its financials show negative gross and operating margins, meaning it currently spends more than it earns, which is a significant risk — the company will need to either grow revenue substantially or cut costs to reach profitability, and its ability to do so in a competitive Southeast Asian healthcare market remains uncertain.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Weak (1/30)
- Growth: Data not available (0/20)
- Cash Flow: Data not available (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)

